• Offer for Industry
  • Young GI
  • Patients
  • Press
  • Newsletter
  • Contact us
UEG Connect
Create myUEG account
  • About
    • To landing page
      • Who we are
      • Boards, Committees & Groups
      • Governance
      • Headquarters Management
      • History
      • What we do
      • Strategic Drivers
      • Year in Review
      • Our Members
      • Specialist Member Societies
      • National Member Societies
      • UEG Community
      • UEG Associates
      • UEG Connect
      • Women in GI
      • Young GIs
      • Researchers
      • Event Calendar
  • Week
    • To landing page
      • Congress Resources
      • UEG Week Recordings ↗
      • CME Accreditation
      • Future UEG Week
      • Programme
      • Postgraduate Teaching
      • Industry
      • Supporters
  • Education
    • To landing page
      • Gutflix - Learning Platform ↗
      • Online Courses ↗
      • Mistakes in... ↗
      • UEG Podcast ↗
      • Webinars ↗
      • Summer School
      • Masterclass
      • Gut Guide
      • Career Development
      • CME in Europe
      • Supporters
  • Research
    • To landing page
      • Horizon Europe Support
      • Start-up Grant
      • Research Projects
      • HoloSurge
      • Intercept
      • InfoGut COST Action
      • White Book 2
      • Main Results
      • Full Reports
      • Materials and Presentations
  • Quality of Care
    • To landing page
      • Search Guidelines ↗
      • Non-English Guidelines
      • How to Develop Guidelines ↗
      • Quality of Care Initiatives
      • Quality Indicators
  • Public Affairs
    • To landing page
      • News
      • Focus Areas
      • Advocacy Toolbox
      • Stakeholder Collaboration
      • Digestive Health Month
      • Position Papers
      • Advocacy Bulletin
      • #EUNewsline
      • MEP Digestive Health Group
  • Publications
    • To landing page
      • Congress Publications
      • Research Publications
      • Public Affairs Publications
      • Education Publications
      • UEG Publications
      • UEG Journal ↗
      • UEG Journal Podcast ↗
  • Opportunities
    • To landing page
      • Top Abstract Prizes
      • National Scholar Award
      • Travel Grants
      • International Scholarship Awards
      • Research Prize
      • Research Fellowship
      • Lifetime Achievement Award
      • Journal Best Paper Award
      • Activities Endorsement
      • Rising Star Awards
      • Clinical Visiting Fellowships
      • Open Positions
      • Talent Pool
  • Gutflix ↗
  • Offer for Industry
  • Young GI
  • Patients
  • Press
  • Newsletter
  • Contact us
Press Release

One in 10 IBS with diarrhoea patients wish they were dead when their condition is bad

August 07, 2018

Eleven percent of irritable bowel syndrome with diarrhoea (IBS-D) patients reveal that they suffer from suicidal thinking when their condition is bad, a new study has found.

The research, published in the UEG Journal, assessed the burden associated with irritable bowel syndrome with diarrhoea by surveying 513 patients and 679 healthcare professionals. A quarter of patients reported that IBS stops them from enjoying life and 11% agreed with the statement; ‘when my IBS is bad, I wish I was dead’.

IBS is a functional bowel disorder, characterised by abdominal pain and altered bowel habits. The disease affects 11% of adults globally, of whom one third experience diarrhoea as the predominant symptom. IBS-D is considered to be a brain-gut interaction disorder and a range of treatment approaches have been proposed, including diet and lifestyle modifications, probiotics and fibre supplements and various prescription and over-the-counter medications.

Over a third of patients reported that they ‘constantly’ worry about whether and when their IBS symptoms will return and one in five stated that IBS had negatively affected their working life. Patients also revealed that, on average, they spend 18 days per month experiencing fatigue or a lack of energy. Half of patients reported that they would use a daily treatment for the rest of their life if it prevented their IBS symptoms (49%) and a ‘willingness to try anything’ to improve their condition (46%).

Despite these alarming statistics, the survey outlined that one third of IBS patients do not think that healthcare professionals take the disease seriously and should provide more support in disease management. When reviewing the attitudes of healthcare professionals towards IBS, results showed that two-thirds agreed that patients should feel listened to and supported, with the vast majority stating that the main aim of their care when managing IBS is significantly improving their patients’ quality of life.

Professor Hans Törnblom, lead author of the study, comments on the findings, “IBS can be an extremely tough, emotional and difficult condition to live with and, in addition to dedicating resources to improve the physical burden of IBS, it is essential that care and investment is committed to providing psychological and emotional support for patients. This should come from multi-disciplined healthcare professionals, as well as family members, friends and colleagues.”

“The majority of IBS sufferers do not seek medical advice for their condition” added Professor Törnblom. “Of those that do speak to a healthcare professional, it is clear that there are high levels of dissatisfaction with the level of care that they currently receive. Healthcare professionals experience a degree of uncertainty and complexity in managing IBS patients and the research indicates the need for higher levels of communication between care providers and patients to facilitate improved patient outcomes.”

Social Sharing
  • About UEG
  • About UEG Week
  • Notes to Editors
  • References
About UEG

UEG, or United European Gastroenterology, is a professional non-profit organisation combining all the leading European medical specialist and national societies focusing on digestive health.

Our member societies represent more than 30,000 specialists from every field of gastroenterology. Together, we provide services for all healthcare professionals and researchers, in the broad area of digestive health. The role of UEG is to take concerted efforts to learn more about digestive disease by prevention, research, diagnosis, cure and raising awareness of their importance. 

To advance the standards of gastroenterological care and knowledge across the world and to reduce the burden of digestive diseases, UEG offers numerous activities and initiatives, including:

  • UEG Week: Organising the best international multidisciplinary gastroenterology congress in the world
  • UEG Research: Supporting cooperation and excellence in digestive health research
  • UEG Journal: Delivering clinical information for digestive health with authority
  • UEG Education: Providing learning oportunities in multiple formats
  • Quality of Care: Improving clinical practice to reduce health inequalities across Europe
  • Public Affairs: Acting as the united voice of European Gastroenterology towards the public and policy makers

Find out more about UEG’s work by visiting www.ueg.eu or contact:    

Luke Paskins on +44 (0)1444 811099 or  

About UEG Week

UEG Week is the largest and most prestigious gastroenterology meeting in Europe and has developed into a global congress. It attracts over 14,000 participants each year, from more than 120 countries, and numbers are steadily rising.

UEG Week provides a forum for basic and clinical scientists from across the globe to present their latest research in digestive and liver diseases, and also features a two-day postgraduate course that brings together top lecturers in their fields for a weekend of interactive learning.

Notes to Editors

For further information, to view the full paper or to arrange an expert interview, please contact Luke Paskins on +44 (0)1444 811099 or

About Professor Hans Törnblom

Professor Hans Törnblom is from the University of Gothenburg, Sweden and is a member of the UEG Public Affairs Committee.

References
  1. Understanding symptom burden and attitudes to irritable bowel syndrome with diarrhoea: Results from patient and healthcare professional surveys. UEG Journal. Published July 2018.
  2. Lacy BE, Mearin F, Chang L, et al. Bowel disorders. Gastroenterology 2016; 150: 1393–1407.
  3. Lovell RM and Ford AC. Global prevalence of and risk factors for irritable bowel syndrome: A meta-analysis. Clinical Gastroenterol Hepatology 2012; 10: 712–721.

Comment

Please log in with your myUEG account to post comments.

Latest Articles
Press Release
Europe must embed patient voices to transform digestive health outcomes, urges new UEG manifesto
Press Release
Microplastics found to change gut microbiome in first human-sample study
Press Release
Artificially sweetened and sugary drinks are both associated with an increased risk of liver disease, study finds
Press Release
Europe faces rising liver cancer epidemic without urgent prevention and early detection measures
Get our newsletter!
Sign up with your email to receive UEG news and updates. We respect your privacy.

Headquarters Management

United European Gastroenterology

Wickenburggasse 1
1080 Vienna, Austria



T: +43 1 997 1639

UEG Week Registration

Mondial Congress & Events

Official UEG Week Registration Partner
Operngasse 20b
1040 Vienna, Austria



T: +43 1 58804 - 0

More

Imprint

Terms & Conditions

Media Policies

Privacy Policy

Change cookie-settings

Social Media

7 767 Followers

23 000 Followers

15 666 Followers

5 866 Followers

3 670 Subscribers

11 399 Subscribers

65 Subscribers

409 Subscribers

UEG copyright 2025. All rights reserved. Use of this website constitutes acceptance of the Privacy Policy and Terms & Conditions.